Studies in melanoma identified that increased β-catenin activation resulted in a decreased CD8 and CD103 dendritic cell population that hampered T cell recruitment into the tumor microenvironment, leading to a T cell exclusion status. This evidence concerns the gene CD8A and neoplasm.